Skip to content

DBVT

DBV Technologies SA

NASDAQ · Healthcare · Biotechnology · FR

$12.35
−1.28%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
P/E 2026E
P/E 2027E
P/E 2028E
54.61x
P/S forward
88.26x

Trailing multiples

Trailing twelve months

P/E TTM
PEG TTM
Price / book
4.84x
Price / sales
Price / cash flow
-3.88x

Enterprise value

Enterprise value
$622.3M
EV / sales
EV / EBITDA
-3.61x
EV / EBIT
-3.44x
Market cap
$776.2M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026